THE GADS ADAPTOR PROTEIN IN T CELL-MEDIATED PREVENTION OF VIRAL PATHOGENESIS
THE GADS ADAPTOR PROTEIN IN T CELL-MEDIATED PREVENTION OF VIRAL PATHOGENESIS
批准号:
7381288
负责人:
THOMAS M. YANKEE
金额:
$18.57万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-27 至 2007-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. T cell-mediated immunity against viral pathogenesis is dependent on the successful transduction of signals from the TCR and CD28 into the cell. The TCR complex contains the antigen recognition and signaling motifs. The CD28 co-receptor delivers a critical second signal, without which the cell would become anergic and undergo apoptosis. The second signal ensures that the antigenic stimulation of the TCR occurs in the appropriate immune context. The goal of this research project is to examine the CD28-mediated signals that are required for T cell activation. Evidence from our laboratory and others suggest that CD28 and the Gads adaptor protein regulate survival and proliferation through the Akt serine/threonine kinase. We hypothesize that Gads, CD28, and Akt are linked in a common signaling pathway that is required for normal T cell development and activation. To test this hypothesis, we will focus on threee specific aims. Specific aim 1 describes the use of Gads-deficient mice to examine CD28-mediated Akt phosphorylation. Specific aim 2 will test the hypothesis that a quaternary signaling complex links CD28, Gads, PI3-K, and c-Cbl that may lead to enhanced Akt phosphorylation. Biochemical experiments examing this putative mutlimeric complex are described. Finally, experiments described in specific aim 3 apply genetic techniques to examine the link between CD28 and Gads. T cell development in Gads-deficient, CD28-deficient, and Gads/CD28 double deficient mice will be analyzed. In summary, the experiments detailed in this proposal will examine the signaling pathway that links CD28, Gads, PI3-K, and c-Cbl.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GADS REGULATES THE SIGNALING THRESHOLD THROUGH THE T CELL RECEPTOR
-
批准号:7959692
-
项目类别:
-
资助金额:$10.13万
-
财政年份:2009
-
负责人:THOMAS M. YANKEE
-
依托单位:
The effects of morphine on the immune responses against HIV in vivo
-
批准号:7687913
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2008
-
负责人:THOMAS M. YANKEE
-
依托单位:
The effects of morphine on the immune responses against HIV in vivo
-
批准号:7622446
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2008
-
负责人:THOMAS M. YANKEE
-
依托单位:
THE ROLE OF THE GADS ADAPTOR PROTEIN IN CD28-MEDIATED IMMUNITY
-
批准号:7720545
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2008
-
负责人:THOMAS M. YANKEE
-
依托单位:
THE ROLE OF THE GADS ADAPTOR PROTEIN IN CD28-MEDIATED IMMUNITY
-
批准号:7609895
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2007
-
负责人:THOMAS M. YANKEE
-
依托单位:
THE ADAPTOR PROTEIN GADS IN CD28-MEDIATED IMMUNITY
-
批准号:7170531
-
项目类别:
-
资助金额:$15.31万
-
财政年份:2005
-
负责人:THOMAS M. YANKEE
-
依托单位:
Flow Cytometry Core: Core 2
-
批准号:8708132
-
项目类别:
-
资助金额:$34.03万
-
财政年份:--
-
负责人:THOMAS M. YANKEE
-
依托单位:
Flow Cytometry Core: Core 2
-
批准号:8461882
-
项目类别:
-
资助金额:$35.67万
-
财政年份:--
-
负责人:THOMAS M. YANKEE
-
依托单位:
Flow Cytometry Core: Core 2
-
批准号:9095397
-
项目类别:
-
资助金额:$34.03万
-
财政年份:--
-
负责人:THOMAS M. YANKEE
-
依托单位:
Flow Cytometry Core: Core 2
-
批准号:8539057
-
项目类别:
-
资助金额:$32.84万
-
财政年份:--
-
负责人:THOMAS M. YANKEE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
-
批准号:82371144
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:汪雪玲
-
依托单位:
职业因素致慢性肌肉骨骼损伤模型及防控研究
-
批准号:81172643
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:王忠旭
-
依托单位:
黄淮海平原典型区域土壤盐渍化演变机制与发生风险防控对策研究
-
批准号:41171178
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2011
-
负责人:刘广明
-
依托单位:
超声防垢阻垢机理的动态力学分析
-
批准号:10574086
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2005
-
负责人:张明铎
-
依托单位: